Skip to main content
. 2024 Dec 6;32(1):e16464. doi: 10.1111/ene.16464

TABLE 1.

Descriptive statistics.

Parameter Patients with residence at diagnosis Patients included with historical data p §
Median (IQR) Median (IQR)
Age at onset (years) 68.2 (60.3–74.4) 68.2 (60.2–74.3) 0.949
Onset–diagnosis interval (months) 9.0 (5.0–13.1) 9.0 (5.0–13.1) 0.194
ΔALSFRS‐R at diagnosis (point loss per month) 0.649 (0.299–1.323) 0.642 (0.290–1.323) 0.220
Survival (years) 2.8 (1.9–4.0) 2.3 (1.5–3.7) 0.853
n (%) n (%) p*
Sex
Male 587 (53.5) 566 (53.4) >0.999
Female 511 (46.5) 494 (46.6)
Site of onset
Bulbar onset 376 (34.3) 362 (34.1) 0.993
Spinal onset 702 (63.9) 678 (64.0)
Respiratory onset 20 (1.8) 20 (1.9)
Genetic mutations
Wild‐type 816 (74.3) 787 (74.3) 0.987
c9orf72, SOD1, TARDBP, FUS 104 (9.5) 103 (9.7)
Not assessed 178 (16.2) 170 (16.0)
Total 1098 (100.0) 1060 (100.0)

Note: Patients with residence at diagnosis and patients with complete residential historical data were compared using Mann–Whitney U test (§) for continuous variable and chi‐square test for categorical variables (*).

Abbreviations: ALSFRS‐R, Revised Amyotrophic Lateral Sclerosis Functional Rating Scale; IQR, interquartile range.